Acceleron Pharma Inc. (XLRN) Declined -5.22% or -1.97 To Price $35.77 On Monday


Acceleron Pharma Inc. (XLRN) declined -5.22% or -1.97 to $35.77. It is approximately 226837 shares traded, which is 77.39% compare to the average total volume 293091. The market cap of XLRN is $1.64 billion. The year to date change is -11.53%. The 52 week price range is from $24.37 to $46.93. Price of XLRN have changed 5.01% during last week. It have changed -3.48% over last month, -14.62% over last 3 months, -1.54% over last 6 months and 12.69% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XLRN is 40.29. It is 12.64% above current price. The 200-day Moving Averages for XLRN is 38.28. It is 7.02% above current price. The 52-week High is 46.93. It is 31.20% from the current price. The 52-week Low is 24.37. It is -31.87% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of XLRN is 9.06 on 2018-04-13. Short % to float is 6.08%. There are some statistics of XLRN. It is has market cap $1.64 billion. The share outstanding is 45.77 million. The average volume is 293091. The revenue is 9.78M. The percent of top 15 Institution holding is 99.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XLRN is -36.71%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XLRN is -34.06%.


Tags:

Share this post